Bringing the fundamentals into focus…
Back to Maravai LifeSciences Holdings, Inc.
How Maravai LifeSciences Holdings, Inc. stacks up
MRVI · against 320 other Healthcare companies of similar size
Growth
14/ 100
Near the bottom of its peers.
Ranked #288 of 321 · scores higher than 10% of peers
Bars: peers in each 10-point band of the growth score22 peers with a growth score of 10–19, including MRVI · Click a bar to see the companies
Why growth scores 14?
Weighted metrics compared with all Healthcare companies.Mainly because of its 3-year revenue growth and revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over three years: weaker than 95% of peers. 3-year revenue growth: -27.3% vs peer median 5.8%
- slower revenue growth over the last year: weaker than 79% of peers. Revenue growth: -5.0% vs peer median 6.1%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = MRVI, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MRVI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 320 reported | -5.0% | 7.2% | 17% | 33% | |
| Earnings per share growthHigher is better · 194 reported | Not reported | 10.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 313 reported | -27.3% | 7.9% | 4% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around MRVI| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 285 | 23.8B CNY (≈$3.3B) | 15 | 54 | |
| 285 | 3.6B USD | 15 | 43 | |
| 285 | 2.3B USD | 15 | 27 | |
| 288 | 14.0B CNY (≈$2.0B) | 14 | 40 | |
| 288 | 2.8B USD | 14 | 22 | |
| 288 | 3.0B CHF (≈$3.5B) | 14 | 33 | |
| 291 | 11.2B CNY (≈$1.6B) | 13 | 61 | |
| 292 | 13.9B CNY (≈$1.9B) | 12 | 29 | |
| 292 | 17.8B CNY (≈$2.5B) | 12 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score